Genomics in Scotland strategy: business and regulatory impact assessment
Business and regulatory impact assessment (BRIA) for the Genomics in Scotland: Building our Future five-year national strategy (2024 to 2029).
11. Legal Aid Impact Test
The strategy is not creating new rights or responsibilities. It is focussed on increasing and improving health care accessibility and our ability to support genomic medicine across Scotland, so should have no impact on the legal aid fund.
Contact
Email: holly.ennis@gov.scot
There is a problem
Thanks for your feedback